Clinical Study
The Use of NeuroAiD (MLC601) in Postischemic Stroke Patients
Table 3
Mean difference (95% CI) in mRS score from baseline to 3 months.
| | MLC601 () | Non-MLC601 () |
| Mean baseline mRS | 3.4 ± 1.04 | 3.2 ± 1.3 | Mean mRS at 3 months | 1.7 ± 1.3 | 2.3 ± 1.5 | Mean difference in mRS from baseline to 3 months (95% CI) | −1.7 (−1.35 to −1.98) | −0.9 (−0.62 to −1.8) | value | <0.001 | <0.001 |
|
|